Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations
1991; Springer Science+Business Media; Volume: 344; Issue: 1 Linguagem: Inglês
10.1007/bf00167387
ISSN1432-1912
AutoresHeiko von der Leyen, Ulrike Mende, Wilfried Meyer, Joachim Neumann, Monika Nose, Wilhelm Schmitz, Hasso Scholz, Jutta Starbatty, Birgitt Stein, Holger Wenzlaff, Volker Döring, Peter Kalmir, Axel Haverich,
Tópico(s)Pulmonary Hypertension Research and Treatments
Referência(s)